|
Volumn 9, Issue 1, 2011, Pages 31-33
|
Pathophysiologic bases of medical therapies for endometriosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANGIOGENESIS INHIBITOR;
ANTIESTROGEN;
ANTIGESTAGEN;
AROMATASE INHIBITOR;
DANAZOL;
GESTAGEN;
GONADORELIN AGONIST;
GONADORELIN ANTAGONIST;
INTERLEUKIN 1;
INTERLEUKIN 8;
LEVONORGESTREL;
MATRIX METALLOPROTEINASE INHIBITOR;
NERVE GROWTH FACTOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
ORAL CONTRACEPTIVE AGENT;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;
STEROID;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
VASCULOTROPIN;
ANTIANGIOGENIC ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
ANTIOXIDANT ACTIVITY;
ARTICLE;
DECIDUALIZATION;
DRUG EFFICACY;
ENDOMETRIOSIS;
HERBAL MEDICINE;
HUMAN;
IMMUNOMODULATION;
INFLAMMATION;
LONG TERM CARE;
NONHUMAN;
PAIN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
THERAPY EFFECT;
UNSPECIFIED SIDE EFFECT;
UTERUS SURGERY;
|
EID: 79953281166
PISSN: 15462501
EISSN: 18787576
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (7)
|